This technology offers several advantages over traditional batch purification including:

• Higher peptide purity
• Increased yield
• Decreased solvent requirements
• Time savings
• Significant reduction of fraction collection, storage, QC, blending, and reprocessing

As a leader in peptide manufacturing and development, AmbioPharm is continuously upgrading equipment and technologies, especially those that can improve our capacity and sustainability. Using our expertise in peptide synthesis, we are able to tackle both simple and complex peptide projects with a proven history of success at research, clinical, and commercial scales.